FDA approves new weight loss drug, first since 2014
Fox News
The Food and Drug Administration (FDA) on Friday approved a weight loss drug for overweight or obese adults, marking the first such authorization since 2014.
The drug works by mimicking the glucagon-like peptide-1 hormone which targets areas of the brain that helps regulate appetite and food intake. The FDA warned that it should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists, or other weight loss products including herbal products, over-the-counter drugs or prescription drugs. The dosage is meant to be increased gradually over 16 to 20 weeks to 2.4 mg once weekly to reduce gastrointestinal side effects.More Related News